A significant increase in the Iba1 staining intensity could be observed in both these sub-regions of the hippocampus between control- and DS-AD-injected mice (p ≤ 0.001) 4 months after the injection (Figure 8), but not after 1 month. The gene discussed is AIF1; the disease is Alzheimer disease.